Formoterol

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Formoterol and local guidelines before prescribing.

Long-acting beta-2 agonist

Mechanism

Long-acting beta-2 agonist with rapid onset.

Uses

Asthma and COPD (maintenance and reliever combined with inhaled steroid).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Tremor, palpitations, headache, hypokalaemia.

Interactions

Beta-blockers antagonise; diuretics and steroids add hypokalaemia.

Contraindications and cautions

Not for acute relief alone

Monitoring

Asthma control, potassium

Pregnancy and breastfeeding

Acceptable

Renal and hepatic impairment

No adjustment

Overdose and reversal

Beta-blocker with caution

Special advice

Used in MART regimens (maintenance and reliever); never alone in asthma.

More from the textbook: uses, cautions and other points
Where it is discussed in the book